Prashant Yadav
@prof-yadav.bsky.social
Better health & economic development through better supply chains, globally. #globalhealth #supplychain #pharmaceuticals #vaccine #access
Some other discussion points re tiered pricing, comparing company-led tiered pricing vs more systematically established bands (not directly related to the MFN clause) that we have deliberated in the past.
cgdev.org/sites/defaul...
cgdev.org/sites/defaul...
cgdev.org
May 12, 2025 at 2:10 AM
Some other discussion points re tiered pricing, comparing company-led tiered pricing vs more systematically established bands (not directly related to the MFN clause) that we have deliberated in the past.
cgdev.org/sites/defaul...
cgdev.org/sites/defaul...
In 👇 we argue that each country would pay a price pharmaceuticals that is commensurate with the value it provides to that country's health system.
pubmed.ncbi.nlm.nih.gov/32185365/
pubmed.ncbi.nlm.nih.gov/32185365/
May 12, 2025 at 2:10 AM
In 👇 we argue that each country would pay a price pharmaceuticals that is commensurate with the value it provides to that country's health system.
pubmed.ncbi.nlm.nih.gov/32185365/
pubmed.ncbi.nlm.nih.gov/32185365/
👇 link to a 2010 study conducted for the Industry Government Forum on Access to Medicines to review current literature on differential pricing, under what conditions does it improve overall welfare, and some operational/practical considerations.
assets.publishing.service.gov.uk/media/5a78b6...
assets.publishing.service.gov.uk/media/5a78b6...
assets.publishing.service.gov.uk
May 12, 2025 at 2:10 AM
👇 link to a 2010 study conducted for the Industry Government Forum on Access to Medicines to review current literature on differential pricing, under what conditions does it improve overall welfare, and some operational/practical considerations.
assets.publishing.service.gov.uk/media/5a78b6...
assets.publishing.service.gov.uk/media/5a78b6...